Cannabis Bioscience International Holdings (CBIH) Income from Continuing Operations (2022 - 2025)
Historic Income from Continuing Operations for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to -$92152.0.
- Cannabis Bioscience International Holdings' Income from Continuing Operations rose 779.54% to -$92152.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$552335.0, marking a year-over-year increase of 110.37%. This contributed to the annual value of -$557627.0 for FY2025, which is 1291.79% up from last year.
- As of Q3 2025, Cannabis Bioscience International Holdings' Income from Continuing Operations stood at -$92152.0, which was up 779.54% from -$237649.0 recorded in Q2 2025.
- Over the past 5 years, Cannabis Bioscience International Holdings' Income from Continuing Operations peaked at -$70827.0 during Q4 2024, and registered a low of -$324655.0 during Q1 2023.
- Moreover, its 4-year median value for Income from Continuing Operations was -$166748.0 (2023), whereas its average is -$176105.7.
- Per our database at Business Quant, Cannabis Bioscience International Holdings' Income from Continuing Operations surged by 5475.04% in 2024 and then plummeted by 9021.66% in 2025.
- Over the past 4 years, Cannabis Bioscience International Holdings' Income from Continuing Operations (Quarter) stood at -$219886.0 in 2022, then surged by 43.41% to -$124428.0 in 2023, then surged by 43.08% to -$70827.0 in 2024, then crashed by 30.11% to -$92152.0 in 2025.
- Its Income from Continuing Operations stands at -$92152.0 for Q3 2025, versus -$237649.0 for Q2 2025 and -$151707.0 for Q1 2025.